CD59 and CD48 expressed by rat retinal pigment epithelial cells are major ligands for the CD2-mediated alternative pathway of T cell activation.
The alternative CD2-mediated pathway of T cell activation, which is independent of MHC/peptide recognition by the TCR/CD3 complex, is dependent upon two signals being received by the CD2 molecule. The natural ligand for CD2 is CD58, but controversy exists over alternative or additional ligands that could deliver the second signal in vivo. We have used rat retinal pigment epithelial cells (RPE), which lack temperature-insensitive ligands for CD2 adhesion, to study Ag-independent T cell activation. Rat RPE cells expressed high levels of CD59 and low levels of another potential CD2 ligand, CD48, both in vitro and in the in vivo model of experimental autoimmune uveoretinitis. When increasing numbers of syngeneic T cells were added to microwell cultures of rat RPE cells, the T cells, even in the absence of any exogenous stimulant in the cultures, underwent spontaneous proliferation. This effect required metabolically active RPE cells, and was IL-2 driven and enhanced in the presence of indomethacin. Proliferation was modulated by phosphatidylinositol-phospholipase C treatment of the RPE, and blocked by mAbs to CD59. Ab cross-linking of CD48 but not CD59 on the RPE was found to induce messenger RNA expression for IL-1 beta, which together with constitutively expressed IL-6 are required costimulatory factors for T cell activation through CD2. This is the first demonstration in a fully syngeneic system that bi-directional signaling involving CD59 and CD48 molecules expressed by physiologically normal, nonhematopoietic, cells can trigger T lymphocyte activation and proliferation through autocrine IL-2 production in the absence of Ag.
Liversidge
J
J
Department of Ophthalmology, University of Aberdeen Medical School, Scotland, United Kingdom.
Dawson
R
R
Hoey
S
S
McKay
D
D
Grabowski
P
P
Forrester
J V
JV
D000818:Animals; D015703:Antigens, CD / Q000276:immunology* / Q000378:metabolism*; D001483:Base Sequence; D018801:CD2 Antigens / Q000502:physiology*; D000071178:CD48 Antigen; D018957:CD59 Antigens / Q000276:immunology* / Q000378:metabolism* / Q000502:physiology; D002460:Cell Line; D018920:Coculture Techniques; D007376:Interleukin-2 / Q000502:physiology; D008024:Ligands; D008213:Lymphocyte Activation / Q000187:drug effects; D008969:Molecular Sequence Data; D043265:Phosphatidylinositol Diacylglycerol-Lyase; D010727:Phosphoric Diester Hydrolases / Q000494:pharmacology; D010857:Pigment Epithelium of Eye / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D011917:Rats, Inbred Lew; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism
D015703:Antigens, CD; D018801:CD2 Antigens; D000071178:CD48 Antigen; D018957:CD59 Antigens; C000604067:Cd48 protein, rat; D007376:Interleukin-2; D008024:Ligands; D010727:Phosphoric Diester Hydrolases; D043265:Phosphatidylinositol Diacylglycerol-Lyase